Research-Driven Intelligence

Turning Healthcare Data Into Market Advantage

Registry analytics, market intelligence, and sales enablement — grounded in peer-reviewed methodology. Founded by surgeon-scientists at Harvard and Heidelberg.

7,709
Citations
300+
Publications
11
Specialties
01

Who We Are

ACP Data Labs is a research intelligence firm that turns large-scale clinical datasets into commercial strategy for the healthcare and life sciences industry. We specialize in registry analytics, market intelligence, and sales enablement — grounded in peer-reviewed methodology.

Founded by surgeon-scientists with appointments at Harvard Medical School and Heidelberg University, our work spans 11 clinical specialties and has been cited over 7,700 times. We measure success in market impact, not just publications.

02

What We Do

Real-World Evidence & Analytics

Large-scale analyses of clinical registries, claims databases, and institutional datasets. Evidence your Medical Affairs team can stake their reputation on — peer-reviewed or white-paper format.

Market & Opportunity Intelligence

Patient population sizing, treatment pattern analysis, competitive landscape mapping. We quantify your addressable market at the procedure, specialty, and facility level.

Sales & Go-to-Market Intelligence

Hospital-level targeting, decision-maker identification, and adoption pathway mapping. We tell your sales team exactly where to go, who to talk to, and what evidence to bring.

Clinical Strategy & Protocol Development

Evidence-to-protocol translation, formulary submission packages, and clinical adoption roadmaps. From research insight to P&T Committee approval.

03

Why ACP Data Labs

"Published, Not PowerPointed"

Our evidence is grounded in peer-reviewed research published in journals like The Lancet, JAMA Surgery, and Annals of Surgery. When we present data, it carries academic weight — not consultant opinion.

"Scientists Who Speak Business"

Our team has authored 300+ publications with 7,709 citations and an h-index of 43. But we measure success in market impact — formulary wins, protocol adoptions, and revenue captured.

"Full-Stack Intelligence"

Most firms do research OR strategy OR sales enablement. We integrate all three from the same dataset, with the same team, in one engagement. No handoffs, no translation loss.

04

Selected Research

The Lancet Regional Health — Americas · 2026

Post-Surgical Opioid Prescribing in the United States: A National Analysis

N = 945,505 patients
JAMA Surgery · 2026

Preoperative Hemoglobin A1C, Glycemic Status, and Postoperative Outcomes in General Surgery

Cited 2 times
EClinicalMedicine · 2025

Delirium After Surgery: Predictors, Complications, and Screening Patterns in the NSQIP

Cited 2 times
Clinical Nutrition · 2025

Comparative Performance of Nutritional Risk Index and Frailty Index in Predicting Surgical Outcomes: 9.7 Million Patients

The American Journal of Surgery · 2019

Impact of Frailty on Outcomes in Surgical Patients: A Systematic Review and Meta-Analysis

Cited 418 times
05

Scientific Leadership Team

ACP

Dr. Adriana C. Panayi, M.D., Ph.D.

Founding Director & Chair of Scientific Leadership
Harvard Medical School · Brigham & Women's Hospital
BG Klinik Ludwigshafen · Heidelberg University
University College London · University of Cambridge
7,709 citations · h-index 43 · 300+ publications
GH

Prof. Dr. Gabriel Hundeshagen, M.D.

Research Associate & Project Manager
Chief of Plastic, Reconstructive & Hand Surgery
BG Klinik Ludwigshafen · Heidelberg University
Co-author network spanning Harvard, Yale, and international institutions
ER

Erik Reisig

Data Strategist
Full-Stack Development · Data Engineering · AI Systems
Commercial Analytics & Market Intelligence
Data infrastructure, pipeline architecture, and commercial intelligence systems
06

Working With Us

All analyses use de-identified, publicly available datasets in compliance with applicable data use agreements and institutional review requirements.